Abbvie Inc (ABBV) Stock Price, Quote & News

Company Profile

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 847 932 7900

Website: www.abbvie.com

Address:

1 North Waukegan Road, North Chicago, United States

67X_ROI_Q1_2026 Feb. 23 at 8:55 PM

$SLS $ABBV Don't Be Surprised when this $4.50 stock is $45 and CLIMBING - its worth over $100 to Big Pharma - the instant the P3 results are announced.

0 · Reply

ByhyeSelo Feb. 23 at 8:49 PM

$SLS $ABBV $ABVX

0 · Reply

HelMarsh Feb. 23 at 7:36 PM

$ABBV defensive pharma leader basing if higher high prints trend confirmation

0 · Reply

biolover Feb. 23 at 7:29 PM

$VKTX some extra requirements such as liver enzyme monitoring on $LLY orforglipron by FDA , or continuous high DC rate in retatrutide trials , or $ABBV moving big on $VKTX and allocation $100 B for R&D next 10 years.

0 · Reply

Duncan_ Feb. 23 at 6:42 PM

$VKTX $ABBV wondering about an all stock offering?

1 · Reply

koditrump Feb. 23 at 6:35 PM

$AAPL $IREN $ABBV $TSLA $NIO

0 · Reply

67X_ROI_Q1_2026 Feb. 23 at 6:30 PM

$SLS $ABVX The Share Price Will Continue Climbing until we see the GPS Phase 3 Registrational Results - and then it Launches. - and Smart Money Knows we are conceivably in the ANY DAY NOW Zone - 24 Months + Enrollment for this Variable Event Driven Readout. $ABBV If you don't know its Gps Immunotherapy causing the Miraculous ALL Pooled P3 Survival - you're in a Rapidly Shrinking Minority ... Smart Money Knows. $ABBV Knows. BAT for Control Arm patients - Aza+VEN Recently Failed 3 Large Phase 3 Trials - including 2 in AML Remission Maintenance.

1 · Reply

vu_jade Feb. 23 at 5:27 PM

$VKTX $ABBV $NVO We’re waiting! #SkOl

0 · Reply

LeisureSuitLarry Feb. 23 at 5:22 PM

$ABBV

0 · Reply

67X_ROI_Q1_2026 Feb. 23 at 5:18 PM

$SLS $ABBV Investment Opportunity of a Lifetime.

4 · Reply

AbbVie to invest $380 million to expand US manufacturing in Illinois

Feb 23, 2026, 11:00 AM EST - 5 hours ago

AbbVie to Invest $380 Million in North Chicago to Further Expand Active Pharmaceutical Ingredient Manufacturing in the United States

Feb 20, 2026, 2:00 AM EST - 3 days ago

U.S. Food and Drug Administration (FDA) Approves Combination Treatment of VENCLEXTA® (venetoclax) and Acalabrutinib for Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL)

Feb 19, 2026, 9:37 AM EST - 4 days ago

AbbVie Declares Quarterly Dividend

Feb 17, 2026, 1:11 AM EST - 6 days ago

AbbVie: Dominating Immunology While Building Oncology Upside

Feb 13, 2026, 12:57 PM EST - 10 days ago

AbbVie Inc. (ABBV) Presents at Piper Sandler Virtual Novel Targets in Immunology Symposium Transcript

Feb 12, 2026, 7:30 AM EST - 11 days ago

54 Stocks, 9 Megatrends: My Favorite Places To Be While Capital Is 'Forced'

AM APH AR ASML AVAV BTU CARR

Feb 11, 2026, 6:49 PM EST - 11 days ago

AbbVie sues US health agency over Botox price controls

Feb 11, 2026, 5:13 PM EST - 11 days ago

Abbvie sues US health agency over Botox

Feb 11, 2026, 4:06 PM EST - 12 days ago

2 Urgent Sells And 2 No Brainer Dividend Buys

AEP AMGN BMY ESS HASI HD PFE

Feb 10, 2026, 9:45 AM EST - 13 days ago

Dividend Kings: No Ideal Buys In February's 57

ABM ADP CWT FRT FTS HRL HTO

Feb 5, 2026, 8:52 AM EST - 18 days ago

AbbVie: The Market Is Getting It Wrong

Feb 5, 2026, 4:25 AM EST - 18 days ago

AbbVie: Skyrizi And Rinvoq Growth Isn't Everything, But It's A Lot

Feb 4, 2026, 6:04 PM EST - 18 days ago

AbbVie: Double-Digit Growth For Immunology Products Continues With HUMIRA Surprise

Feb 4, 2026, 5:45 PM EST - 18 days ago

AbbVie Q4 Earnings Review: I May Have Just Made A Huge Mistake

Feb 4, 2026, 3:39 PM EST - 19 days ago

AbbVie's Immunology Fortress Can't Hide Cracks In Diversification (Downgrade)

Feb 4, 2026, 1:20 PM EST - 19 days ago

AbbVie Inc. (ABBV) Q4 2025 Earnings Call Transcript

Feb 4, 2026, 12:38 PM EST - 19 days ago

AbbVie's Inflammation Drug Humira Slows, But Skyrizi, Rinvoq Drive Revenue Growth

Feb 4, 2026, 8:34 AM EST - 19 days ago

AbbVie Revenue Rises on Immunology Growth

Feb 4, 2026, 8:18 AM EST - 19 days ago

AbbVie Earnings Beat Wall Street Expectations. The Stock Is Falling Anyway.

Feb 4, 2026, 7:51 AM EST - 19 days ago

AbbVie forecasts 2026 profit above estimates on strong sales of newer immunology drugs

Feb 4, 2026, 7:48 AM EST - 19 days ago

AbbVie Reports Full-Year and Fourth-Quarter 2025 Financial Results

Feb 3, 2026, 8:50 AM EST - 20 days ago

Allergan Aesthetics Continues Its Mission of Empowering Women Through the Faces of Natrelle® Testimonial Program

Feb 3, 2026, 8:00 AM EST - 20 days ago

AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib (RINVOQ®) in Adults and Adolescents With Vitiligo

Jan 29, 2026, 10:30 PM EST - 24 days ago

Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance

ABVX CVLT FIX FTAI GKOS GMAB HLI

Jan 29, 2026, 10:10 AM EST - 25 days ago

10 Highest Rated Dividend Kings For Generations Of Income

ABM ABT ADM BDX BKH KMB KO

Jan 29, 2026, 8:00 AM EST - 25 days ago

AbbVie Launches Love in Mind™ to Spotlight the Emotional Impact of Migraine on Romantic Relationships

Jan 28, 2026, 8:00 AM EST - 26 days ago

Allergan Aesthetics Unveils New Data Across Facial Injectables On-Market and Emerging Portfolio at IMCAS 2026 Showcasing Enduring Strength in Advancing Aesthetics Medicine

Jan 27, 2026, 4:52 PM EST - 26 days ago

US Medicare names Eli Lilly, Pfizer and AbbVie drugs for next Medicare price talks

LLY PFE

Jan 27, 2026, 9:34 AM EST - 27 days ago

The AbbVie Foundation Is Now Accepting Applications to Participate in the 2026 AbbVie Foundation Health Equity Accelerator

Jan 25, 2026, 10:11 PM EST - 4 weeks ago

Best Dividend Kings: January 2026

ABM ABT ADM ADP AWR BDX BKH

$AbbVie Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)$

Jan 16, 2026, 1:43 PM EST - 5 weeks ago

AbbVie Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Jan 16, 2026, 1:35 PM EST - 5 weeks ago

Genmab and AbbVie's blood cancer drug fails to improve survival in late-stage study

GMAB

Jan 14, 2026, 5:45 PM EST - 5 weeks ago

AbbVie Inc. (ABBV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 14, 2026, 2:01 PM EST - 5 weeks ago

AbbVie plans to build out its presence in obesity market

Jan 13, 2026, 7:22 AM EST - 5 weeks ago

AbbVie reaches 3-year deal with White House to lower drug prices

Jan 13, 2026, 5:24 AM EST - 5 weeks ago

AbbVie Strikes a $100 Billion Deal With Trump. How the Drugmaker Will Dodge Tariffs.

Jan 12, 2026, 7:03 PM EST - 5 weeks ago

AbbVie Strikes $100 Billion Investment Deal With Trump, Will Lower Medicaid Prices

Jan 12, 2026, 6:57 PM EST - 5 weeks ago

Abbvie, US reach agreement to cut drug prices

Jan 12, 2026, 6:30 PM EST - 5 weeks ago

AbbVie and Trump Administration Reach Agreement to Improve Access and Affordability for Americans

Jan 12, 2026, 7:39 AM EST - 6 weeks ago

AbbVie, RemeGen partner on experimental solid tumor treatment

Jan 12, 2026, 7:30 AM EST - 6 weeks ago

AbbVie and RemeGen Announce Exclusive Licensing Agreement to Develop A Novel Bispecific Antibody for Advanced Solid Tumors

Jan 12, 2026, 6:00 AM EST - 6 weeks ago

AbbVie to Acquire Arizona Manufacturing Facility, Further Strengthening Manufacturing Capabilities in the United States

WST

Jan 12, 2026, 6:00 AM EST - 6 weeks ago

West Signs Agreement to Sell the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System to AbbVie

WST

Jan 12, 2026, 5:12 AM EST - 6 weeks ago

Dividend Income: Lanny's November 2025 Summary

AFL CAT COF CVS CZNC EMR ETN

Jan 10, 2026, 9:30 AM EST - 6 weeks ago

MoneyShow's Best Investment Ideas For 2026: Part 1

ABR ACHR ARE ARES ASTS

Jan 8, 2026, 12:07 PM EST - 6 weeks ago

AbbVie: The Dividend Does Not Lie

Jan 8, 2026, 7:38 AM EST - 6 weeks ago

AbbVie Denies It's in Talks to Buy Revolution Medicines. Both Stocks Are Falling.

RVMD

Jan 7, 2026, 2:58 PM EST - 6 weeks ago

AbbVie in talks to buy biotech Revolution Medicines, WSJ reports

RVMD

Jan 7, 2026, 2:48 PM EST - 6 weeks ago

AbbVie Near Deal for Revolution Medicines

RVMD

67X_ROI_Q1_2026 Feb. 23 at 8:55 PM

$SLS $ABBV Don't Be Surprised when this $4.50 stock is $45 and CLIMBING - its worth over $100 to Big Pharma - the instant the P3 results are announced.

0 · Reply

ByhyeSelo Feb. 23 at 8:49 PM

$SLS $ABBV $ABVX

0 · Reply

HelMarsh Feb. 23 at 7:36 PM

$ABBV defensive pharma leader basing if higher high prints trend confirmation

0 · Reply

biolover Feb. 23 at 7:29 PM

0 · Reply

Duncan_ Feb. 23 at 6:42 PM

$VKTX $ABBV wondering about an all stock offering?

1 · Reply

koditrump Feb. 23 at 6:35 PM

$AAPL $IREN $ABBV $TSLA $NIO

0 · Reply

67X_ROI_Q1_2026 Feb. 23 at 6:30 PM

1 · Reply

vu_jade Feb. 23 at 5:27 PM

$VKTX $ABBV $NVO We’re waiting! #SkOl

0 · Reply

LeisureSuitLarry Feb. 23 at 5:22 PM

$ABBV

0 · Reply

67X_ROI_Q1_2026 Feb. 23 at 5:18 PM

$SLS $ABBV Investment Opportunity of a Lifetime.

4 · Reply

wwmeinc Feb. 23 at 4:46 PM

$VKTX $NVO $LLY $JNJ $ABBV ......With a headline leading with "obsolete"....hmmm.....billions and billions now hanging on NVO's next move...big bucks to the C-suite holder for just these kinds of decision making 'duties'.....talk about having the spotlight of the drug world on them...guessing NVO is not feeling the heat ;) Not! glta "Søren Løntoft Hansen, a senior analyst at Denmark’s AL Sydbank, said: “This is something of a swing and a miss.” He added: “It is difficult to assess whether this data will influence Novo Nordisk’s decision to launch CagriSema on the market.”" https://www.theguardian.com/business/2026/feb/23/wegovy-ozempic-weight-loss-drug-novo-nordisk-cagrisema

0 · Reply

67X_ROI_Q1_2026 Feb. 23 at 3:38 PM

$SLS $ABBV If you don't know its Gps Immunotherapy causing the Miraculous ALL Pooled P3 Survival - you're in a Shrinking Minority ... Smart Money Knows. $ABBV Knows.

0 · Reply

KetCopyPaste Feb. 23 at 3:27 PM

AbbVie $ABBV + Viking Therapeutics $VKTX: Why This Is a Credible Strategic Fit A Full Executive Summary https://www.reddit.com/r/biotech_stocks/comments/1r7bvot/abbvie_abbv_viking_therapeutics_vktx_why_this_is/?utm_source=share&utm_medium=web3x&utm_name=web3xcss&utm_term=1&utm_content=share_button

0 · Reply

TrustButVerifi Feb. 23 at 3:26 PM

$VKTX BP alert! @ $NVO $MRK $ABBV $BMY Fk your next generation and look for this generation as Lilly is gonna eat all your lunch if U dont wake the fk up!

0 · Reply

biolover Feb. 23 at 3:14 PM

$VKTX $NVO may not have enough capacity for Viking anymore particularly if they wait a few weeks I think will be $ABBV

0 · Reply

TrustButVerifi Feb. 23 at 2:42 PM

$VKTX $ABBV $NVO

0 · Reply

ZacksResearch Feb. 23 at 1:24 PM

$JNJ vs. $ABBV — this healthcare heavyweight battle just got real. JNJ’s diversified model, a massive $32B R&D push, and a 48% stock surge over the past year are raising the stakes as it fights AbbVie for dominance amid looming patent cliffs. This isn’t just stability vs. growth — it’s a strategic arms race. Who’s better positioned for the next leg? Discover the full breakdown here 👉 https://www.zacks.com/stock/news/2873271/johnson-johnson-vs-abbvie-a-growth-showdown-amid-patent-cliffs?cid=sm-stocktwits-2-2873271-teaser-34547&ADID=SYND_STOCKTWITS_TWEET_2_2873271_TEASER_34547

0 · Reply

dewmoore Feb. 23 at 12:33 PM

$SLS Good Morning SLS Soldiers! I have one thing to say. Release the "KEYRUDA KILLER" now! Stop the damn trial!!!!!! -----PS -- BUYOUT BOYS we want our $100+ --- ummm $PFE and $MRK I would get started NOW don't wait on a stoppage or 80th death...before you know it $ABBV or $LLY will roll up on your girfriend (you know SLS is dating both Abbvie + Merck) with a BIGGER diamond! Don't be an idiot -- close the $40B deal NOW before anyone even opens their mouth!!!! This message is brought to you by the happy smart EARLY believers in $SLS :) That's all

0 · Reply

ZacksResearch Feb. 23 at 12:24 PM

$JNJ or $ABBV — which pharma giant is your best bet? 🤔 📈 J&J boasts diversified growth with new drug approvals, while AbbVie rides on Skyrizi and Rinvoq's success. Yet, both face patent headwinds and valuation challenges. Deep dive into their growth prospects here 👉 https://www.zacks.com/stock/news/2873271/johnson-johnson-vs-abbvie-a-growth-showdown-amid-patent-cliffs?cid=sm-stocktwits-2-2873271-body-34548&ADID=SYND_STOCKTWITS_TWEET_2_2873271_BODY_34548

0 · Reply

biolover Feb. 23 at 12:20 PM

$VKTX today is day $ABBV realizes GUBRA not only inadequate by itself but it has to pay big to get access to leadership.

1 · Reply

Rollercoaster22 Feb. 23 at 10:14 AM

$VKTX It's going to be an epic bidding war between $NVO and $ABBV

0 · Reply

The__short_squeezer Feb. 22 at 10:00 PM

$MU $MA $ORCL $COST $ABBV

1 · Reply

Market Cap	397.33B
Revenue (ttm)	61.16B
Net Income (ttm)	4.23B
EPS (ttm)	N/A
PE Ratio	22.43
Forward PE	15.38
Profit Margin	6.91%
Debt to Equity Ratio	-26.45

Volume	3,585,963
Avg Vol	6,797,128
Day's Range	N/A - N/A
Shares Out	1.77B
Stochastic %K	39%
Beta	0.35
Analysts	Strong Sell
Price Target	$247.42